Global Acyclovir Active Pharmaceutical Ingredient (API) Market Growth 2025-2031
The global Acyclovir Active Pharmaceutical Ingredient (API) market size is predicted to grow from US$ 42.3 million in 2025 to US$ 54.5 million in 2031; it is expected to grow at a CAGR of 4.3% from 2025 to 2031.
Acyclovir API refers to the active pharmaceutical ingredient used in the formulation of antiviral medications. It is a synthetic nucleoside analogue that inhibits viral DNA polymerase, primarily used for the treatment of herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections.
United States market for Acyclovir Active Pharmaceutical Ingredient (API) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Acyclovir Active Pharmaceutical Ingredient (API) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Acyclovir Active Pharmaceutical Ingredient (API) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Acyclovir Active Pharmaceutical Ingredient (API) players cover Fuxiang Pharmaceuticals, Zhejiang Zhebei Pharmaceuticals, Hongyuan Pharmaceuticals, Xinxiang Pharmaceuticals, Hubei Yitai Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Acyclovir Active Pharmaceutical Ingredient (API) Industry Forecast” looks at past sales and reviews total world Acyclovir Active Pharmaceutical Ingredient (API) sales in 2024, providing a comprehensive analysis by region and market sector of projected Acyclovir Active Pharmaceutical Ingredient (API) sales for 2025 through 2031. With Acyclovir Active Pharmaceutical Ingredient (API) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acyclovir Active Pharmaceutical Ingredient (API) industry.
This Insight Report provides a comprehensive analysis of the global Acyclovir Active Pharmaceutical Ingredient (API) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acyclovir Active Pharmaceutical Ingredient (API) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acyclovir Active Pharmaceutical Ingredient (API) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acyclovir Active Pharmaceutical Ingredient (API) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acyclovir Active Pharmaceutical Ingredient (API).
This report presents a comprehensive overview, market shares, and growth opportunities of Acyclovir Active Pharmaceutical Ingredient (API) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Acyclovir Active Pharmaceutical Ingredient (API) market?
What factors are driving Acyclovir Active Pharmaceutical Ingredient (API) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Acyclovir Active Pharmaceutical Ingredient (API) market opportunities vary by end market size?
How does Acyclovir Active Pharmaceutical Ingredient (API) break out by Type, by Application?
Acyclovir API refers to the active pharmaceutical ingredient used in the formulation of antiviral medications. It is a synthetic nucleoside analogue that inhibits viral DNA polymerase, primarily used for the treatment of herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections.
United States market for Acyclovir Active Pharmaceutical Ingredient (API) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Acyclovir Active Pharmaceutical Ingredient (API) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Acyclovir Active Pharmaceutical Ingredient (API) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Acyclovir Active Pharmaceutical Ingredient (API) players cover Fuxiang Pharmaceuticals, Zhejiang Zhebei Pharmaceuticals, Hongyuan Pharmaceuticals, Xinxiang Pharmaceuticals, Hubei Yitai Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Acyclovir Active Pharmaceutical Ingredient (API) Industry Forecast” looks at past sales and reviews total world Acyclovir Active Pharmaceutical Ingredient (API) sales in 2024, providing a comprehensive analysis by region and market sector of projected Acyclovir Active Pharmaceutical Ingredient (API) sales for 2025 through 2031. With Acyclovir Active Pharmaceutical Ingredient (API) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acyclovir Active Pharmaceutical Ingredient (API) industry.
This Insight Report provides a comprehensive analysis of the global Acyclovir Active Pharmaceutical Ingredient (API) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acyclovir Active Pharmaceutical Ingredient (API) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acyclovir Active Pharmaceutical Ingredient (API) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acyclovir Active Pharmaceutical Ingredient (API) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acyclovir Active Pharmaceutical Ingredient (API).
This report presents a comprehensive overview, market shares, and growth opportunities of Acyclovir Active Pharmaceutical Ingredient (API) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Purity ? 98%
- Purity ? 99%
- Pharmaceuticals
- Scientific Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Fuxiang Pharmaceuticals
- Zhejiang Zhebei Pharmaceuticals
- Hongyuan Pharmaceuticals
- Xinxiang Pharmaceuticals
- Hubei Yitai Pharmaceuticals
- Chongqing Qingyang Pharmaceuticals
- Zhejiang Chengyi Pharmaceuticals
- Tianjin Junan Biopharmaceuticals
- Shanghai Pharmaceuticals Kangli
- Zhejiang Chetou Pharmaceuticals
- Mangalam
- Adrovent Pharma
- Vinuthana
- Atom pharma
- Clearsynth
What is the 10-year outlook for the global Acyclovir Active Pharmaceutical Ingredient (API) market?
What factors are driving Acyclovir Active Pharmaceutical Ingredient (API) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Acyclovir Active Pharmaceutical Ingredient (API) market opportunities vary by end market size?
How does Acyclovir Active Pharmaceutical Ingredient (API) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Acyclovir Active Pharmaceutical Ingredient (API) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Acyclovir Active Pharmaceutical Ingredient (API) by Country/Region, 2020, 2024 & 2031
2.2 Acyclovir Active Pharmaceutical Ingredient (API) Segment by Type
2.2.1 Purity ? 98%
2.2.2 Purity ? 99%
2.3 Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type
2.3.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
2.3.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Type (2020-2025)
2.4 Acyclovir Active Pharmaceutical Ingredient (API) Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Scientific Research
2.5 Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application
2.5.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Market Share by Application (2020-2025)
2.5.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Breakdown Data by Company
3.1.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales by Company (2020-2025)
3.1.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Company (2020-2025)
3.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue by Company (2020-2025)
3.2.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Company (2020-2025)
3.2.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Company (2020-2025)
3.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Company
3.4 Key Manufacturers Acyclovir Active Pharmaceutical Ingredient (API) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Acyclovir Active Pharmaceutical Ingredient (API) Product Location Distribution
3.4.2 Players Acyclovir Active Pharmaceutical Ingredient (API) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ACYCLOVIR ACTIVE PHARMACEUTICAL INGREDIENT (API) BY GEOGRAPHIC REGION
4.1 World Historic Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Geographic Region (2020-2025)
4.1.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Country/Region (2020-2025)
4.2.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Growth
4.4 APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Growth
4.5 Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Growth
4.6 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Growth
5 AMERICAS
5.1 Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country
5.1.1 Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025)
5.1.2 Americas Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025)
5.2 Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025)
5.3 Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region
6.1.1 APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region (2020-2025)
6.1.2 APAC Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region (2020-2025)
6.2 APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025)
6.3 APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Acyclovir Active Pharmaceutical Ingredient (API) by Country
7.1.1 Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025)
7.1.2 Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025)
7.2 Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025)
7.3 Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) by Country
8.1.1 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025)
8.2 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025)
8.3 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acyclovir Active Pharmaceutical Ingredient (API)
10.3 Manufacturing Process Analysis of Acyclovir Active Pharmaceutical Ingredient (API)
10.4 Industry Chain Structure of Acyclovir Active Pharmaceutical Ingredient (API)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Acyclovir Active Pharmaceutical Ingredient (API) Distributors
11.3 Acyclovir Active Pharmaceutical Ingredient (API) Customer
12 WORLD FORECAST REVIEW FOR ACYCLOVIR ACTIVE PHARMACEUTICAL INGREDIENT (API) BY GEOGRAPHIC REGION
12.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Size Forecast by Region
12.1.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Forecast by Region (2026-2031)
12.1.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Acyclovir Active Pharmaceutical Ingredient (API) Forecast by Type (2026-2031)
12.7 Global Acyclovir Active Pharmaceutical Ingredient (API) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Fuxiang Pharmaceuticals
13.1.1 Fuxiang Pharmaceuticals Company Information
13.1.2 Fuxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.1.3 Fuxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Fuxiang Pharmaceuticals Main Business Overview
13.1.5 Fuxiang Pharmaceuticals Latest Developments
13.2 Zhejiang Zhebei Pharmaceuticals
13.2.1 Zhejiang Zhebei Pharmaceuticals Company Information
13.2.2 Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.2.3 Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zhejiang Zhebei Pharmaceuticals Main Business Overview
13.2.5 Zhejiang Zhebei Pharmaceuticals Latest Developments
13.3 Hongyuan Pharmaceuticals
13.3.1 Hongyuan Pharmaceuticals Company Information
13.3.2 Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.3.3 Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Hongyuan Pharmaceuticals Main Business Overview
13.3.5 Hongyuan Pharmaceuticals Latest Developments
13.4 Xinxiang Pharmaceuticals
13.4.1 Xinxiang Pharmaceuticals Company Information
13.4.2 Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.4.3 Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Xinxiang Pharmaceuticals Main Business Overview
13.4.5 Xinxiang Pharmaceuticals Latest Developments
13.5 Hubei Yitai Pharmaceuticals
13.5.1 Hubei Yitai Pharmaceuticals Company Information
13.5.2 Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.5.3 Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hubei Yitai Pharmaceuticals Main Business Overview
13.5.5 Hubei Yitai Pharmaceuticals Latest Developments
13.6 Chongqing Qingyang Pharmaceuticals
13.6.1 Chongqing Qingyang Pharmaceuticals Company Information
13.6.2 Chongqing Qingyang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.6.3 Chongqing Qingyang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Chongqing Qingyang Pharmaceuticals Main Business Overview
13.6.5 Chongqing Qingyang Pharmaceuticals Latest Developments
13.7 Zhejiang Chengyi Pharmaceuticals
13.7.1 Zhejiang Chengyi Pharmaceuticals Company Information
13.7.2 Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.7.3 Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Zhejiang Chengyi Pharmaceuticals Main Business Overview
13.7.5 Zhejiang Chengyi Pharmaceuticals Latest Developments
13.8 Tianjin Junan Biopharmaceuticals
13.8.1 Tianjin Junan Biopharmaceuticals Company Information
13.8.2 Tianjin Junan Biopharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.8.3 Tianjin Junan Biopharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Tianjin Junan Biopharmaceuticals Main Business Overview
13.8.5 Tianjin Junan Biopharmaceuticals Latest Developments
13.9 Shanghai Pharmaceuticals Kangli
13.9.1 Shanghai Pharmaceuticals Kangli Company Information
13.9.2 Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.9.3 Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Shanghai Pharmaceuticals Kangli Main Business Overview
13.9.5 Shanghai Pharmaceuticals Kangli Latest Developments
13.10 Zhejiang Chetou Pharmaceuticals
13.10.1 Zhejiang Chetou Pharmaceuticals Company Information
13.10.2 Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.10.3 Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Zhejiang Chetou Pharmaceuticals Main Business Overview
13.10.5 Zhejiang Chetou Pharmaceuticals Latest Developments
13.11 Mangalam
13.11.1 Mangalam Company Information
13.11.2 Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.11.3 Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Mangalam Main Business Overview
13.11.5 Mangalam Latest Developments
13.12 Adrovent Pharma
13.12.1 Adrovent Pharma Company Information
13.12.2 Adrovent Pharma Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.12.3 Adrovent Pharma Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Adrovent Pharma Main Business Overview
13.12.5 Adrovent Pharma Latest Developments
13.13 Vinuthana
13.13.1 Vinuthana Company Information
13.13.2 Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.13.3 Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Vinuthana Main Business Overview
13.13.5 Vinuthana Latest Developments
13.14 Atom pharma
13.14.1 Atom pharma Company Information
13.14.2 Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.14.3 Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Atom pharma Main Business Overview
13.14.5 Atom pharma Latest Developments
13.15 Clearsynth
13.15.1 Clearsynth Company Information
13.15.2 Clearsynth Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.15.3 Clearsynth Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Clearsynth Main Business Overview
13.15.5 Clearsynth Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Acyclovir Active Pharmaceutical Ingredient (API) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Acyclovir Active Pharmaceutical Ingredient (API) by Country/Region, 2020, 2024 & 2031
2.2 Acyclovir Active Pharmaceutical Ingredient (API) Segment by Type
2.2.1 Purity ? 98%
2.2.2 Purity ? 99%
2.3 Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type
2.3.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
2.3.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Type (2020-2025)
2.4 Acyclovir Active Pharmaceutical Ingredient (API) Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Scientific Research
2.5 Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application
2.5.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Market Share by Application (2020-2025)
2.5.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Breakdown Data by Company
3.1.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales by Company (2020-2025)
3.1.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Company (2020-2025)
3.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue by Company (2020-2025)
3.2.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Company (2020-2025)
3.2.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Company (2020-2025)
3.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Company
3.4 Key Manufacturers Acyclovir Active Pharmaceutical Ingredient (API) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Acyclovir Active Pharmaceutical Ingredient (API) Product Location Distribution
3.4.2 Players Acyclovir Active Pharmaceutical Ingredient (API) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ACYCLOVIR ACTIVE PHARMACEUTICAL INGREDIENT (API) BY GEOGRAPHIC REGION
4.1 World Historic Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Geographic Region (2020-2025)
4.1.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Country/Region (2020-2025)
4.2.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Growth
4.4 APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Growth
4.5 Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Growth
4.6 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Growth
5 AMERICAS
5.1 Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country
5.1.1 Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025)
5.1.2 Americas Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025)
5.2 Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025)
5.3 Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region
6.1.1 APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region (2020-2025)
6.1.2 APAC Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region (2020-2025)
6.2 APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025)
6.3 APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Acyclovir Active Pharmaceutical Ingredient (API) by Country
7.1.1 Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025)
7.1.2 Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025)
7.2 Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025)
7.3 Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) by Country
8.1.1 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025)
8.2 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025)
8.3 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acyclovir Active Pharmaceutical Ingredient (API)
10.3 Manufacturing Process Analysis of Acyclovir Active Pharmaceutical Ingredient (API)
10.4 Industry Chain Structure of Acyclovir Active Pharmaceutical Ingredient (API)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Acyclovir Active Pharmaceutical Ingredient (API) Distributors
11.3 Acyclovir Active Pharmaceutical Ingredient (API) Customer
12 WORLD FORECAST REVIEW FOR ACYCLOVIR ACTIVE PHARMACEUTICAL INGREDIENT (API) BY GEOGRAPHIC REGION
12.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Size Forecast by Region
12.1.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Forecast by Region (2026-2031)
12.1.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Acyclovir Active Pharmaceutical Ingredient (API) Forecast by Type (2026-2031)
12.7 Global Acyclovir Active Pharmaceutical Ingredient (API) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Fuxiang Pharmaceuticals
13.1.1 Fuxiang Pharmaceuticals Company Information
13.1.2 Fuxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.1.3 Fuxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Fuxiang Pharmaceuticals Main Business Overview
13.1.5 Fuxiang Pharmaceuticals Latest Developments
13.2 Zhejiang Zhebei Pharmaceuticals
13.2.1 Zhejiang Zhebei Pharmaceuticals Company Information
13.2.2 Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.2.3 Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zhejiang Zhebei Pharmaceuticals Main Business Overview
13.2.5 Zhejiang Zhebei Pharmaceuticals Latest Developments
13.3 Hongyuan Pharmaceuticals
13.3.1 Hongyuan Pharmaceuticals Company Information
13.3.2 Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.3.3 Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Hongyuan Pharmaceuticals Main Business Overview
13.3.5 Hongyuan Pharmaceuticals Latest Developments
13.4 Xinxiang Pharmaceuticals
13.4.1 Xinxiang Pharmaceuticals Company Information
13.4.2 Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.4.3 Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Xinxiang Pharmaceuticals Main Business Overview
13.4.5 Xinxiang Pharmaceuticals Latest Developments
13.5 Hubei Yitai Pharmaceuticals
13.5.1 Hubei Yitai Pharmaceuticals Company Information
13.5.2 Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.5.3 Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hubei Yitai Pharmaceuticals Main Business Overview
13.5.5 Hubei Yitai Pharmaceuticals Latest Developments
13.6 Chongqing Qingyang Pharmaceuticals
13.6.1 Chongqing Qingyang Pharmaceuticals Company Information
13.6.2 Chongqing Qingyang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.6.3 Chongqing Qingyang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Chongqing Qingyang Pharmaceuticals Main Business Overview
13.6.5 Chongqing Qingyang Pharmaceuticals Latest Developments
13.7 Zhejiang Chengyi Pharmaceuticals
13.7.1 Zhejiang Chengyi Pharmaceuticals Company Information
13.7.2 Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.7.3 Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Zhejiang Chengyi Pharmaceuticals Main Business Overview
13.7.5 Zhejiang Chengyi Pharmaceuticals Latest Developments
13.8 Tianjin Junan Biopharmaceuticals
13.8.1 Tianjin Junan Biopharmaceuticals Company Information
13.8.2 Tianjin Junan Biopharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.8.3 Tianjin Junan Biopharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Tianjin Junan Biopharmaceuticals Main Business Overview
13.8.5 Tianjin Junan Biopharmaceuticals Latest Developments
13.9 Shanghai Pharmaceuticals Kangli
13.9.1 Shanghai Pharmaceuticals Kangli Company Information
13.9.2 Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.9.3 Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Shanghai Pharmaceuticals Kangli Main Business Overview
13.9.5 Shanghai Pharmaceuticals Kangli Latest Developments
13.10 Zhejiang Chetou Pharmaceuticals
13.10.1 Zhejiang Chetou Pharmaceuticals Company Information
13.10.2 Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.10.3 Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Zhejiang Chetou Pharmaceuticals Main Business Overview
13.10.5 Zhejiang Chetou Pharmaceuticals Latest Developments
13.11 Mangalam
13.11.1 Mangalam Company Information
13.11.2 Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.11.3 Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Mangalam Main Business Overview
13.11.5 Mangalam Latest Developments
13.12 Adrovent Pharma
13.12.1 Adrovent Pharma Company Information
13.12.2 Adrovent Pharma Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.12.3 Adrovent Pharma Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Adrovent Pharma Main Business Overview
13.12.5 Adrovent Pharma Latest Developments
13.13 Vinuthana
13.13.1 Vinuthana Company Information
13.13.2 Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.13.3 Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Vinuthana Main Business Overview
13.13.5 Vinuthana Latest Developments
13.14 Atom pharma
13.14.1 Atom pharma Company Information
13.14.2 Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.14.3 Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Atom pharma Main Business Overview
13.14.5 Atom pharma Latest Developments
13.15 Clearsynth
13.15.1 Clearsynth Company Information
13.15.2 Clearsynth Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.15.3 Clearsynth Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Clearsynth Main Business Overview
13.15.5 Clearsynth Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity ? 98%
Table 4. Major Players of Purity ? 99%
Table 5. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025) & (Tons)
Table 6. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
Table 7. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Type (2020-2025) & ($ million)
Table 8. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2020-2025)
Table 9. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Type (2020-2025) & (US$/Ton)
Table 10. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale by Application (2020-2025) & (Tons)
Table 11. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Market Share by Application (2020-2025)
Table 12. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Application (2020-2025) & ($ million)
Table 13. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2020-2025)
Table 14. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Application (2020-2025) & (US$/Ton)
Table 15. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Company (2020-2025) & (Tons)
Table 16. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Company (2020-2025)
Table 17. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Company (2020-2025)
Table 19. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Company (2020-2025) & (US$/Ton)
Table 20. Key Manufacturers Acyclovir Active Pharmaceutical Ingredient (API) Producing Area Distribution and Sales Area
Table 21. Players Acyclovir Active Pharmaceutical Ingredient (API) Products Offered
Table 22. Acyclovir Active Pharmaceutical Ingredient (API) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Geographic Region (2020-2025) & (Tons)
Table 26. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share Geographic Region (2020-2025)
Table 27. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country/Region (2020-2025) & (Tons)
Table 30. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country/Region (2020-2025)
Table 31. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025) & (Tons)
Table 34. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2020-2025)
Table 35. Americas Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025) & (Tons)
Table 37. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025) & (Tons)
Table 38. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region (2020-2025) & (Tons)
Table 39. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2020-2025)
Table 40. APAC Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025) & (Tons)
Table 42. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025) & (Tons)
Table 43. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025) & (Tons)
Table 44. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025) & (Tons)
Table 46. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025) & (Tons)
Table 47. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025) & (Tons)
Table 48. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025) & (Tons)
Table 50. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Acyclovir Active Pharmaceutical Ingredient (API)
Table 52. Key Market Challenges & Risks of Acyclovir Active Pharmaceutical Ingredient (API)
Table 53. Key Industry Trends of Acyclovir Active Pharmaceutical Ingredient (API)
Table 54. Acyclovir Active Pharmaceutical Ingredient (API) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Acyclovir Active Pharmaceutical Ingredient (API) Distributors List
Table 57. Acyclovir Active Pharmaceutical Ingredient (API) Customer List
Table 58. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Region (2026-2031) & (Tons)
Table 59. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2026-2031) & (Tons)
Table 61. Americas Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Region (2026-2031) & (Tons)
Table 63. APAC Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2026-2031) & (Tons)
Table 65. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2026-2031) & (Tons)
Table 67. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Type (2026-2031) & (Tons)
Table 69. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Application (2026-2031) & (Tons)
Table 71. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Fuxiang Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 73. Fuxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 74. Fuxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Fuxiang Pharmaceuticals Main Business
Table 76. Fuxiang Pharmaceuticals Latest Developments
Table 77. Zhejiang Zhebei Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 78. Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 79. Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Zhejiang Zhebei Pharmaceuticals Main Business
Table 81. Zhejiang Zhebei Pharmaceuticals Latest Developments
Table 82. Hongyuan Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 83. Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 84. Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Hongyuan Pharmaceuticals Main Business
Table 86. Hongyuan Pharmaceuticals Latest Developments
Table 87. Xinxiang Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 88. Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 89. Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Xinxiang Pharmaceuticals Main Business
Table 91. Xinxiang Pharmaceuticals Latest Developments
Table 92. Hubei Yitai Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 93. Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 94. Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Hubei Yitai Pharmaceuticals Main Business
Table 96. Hubei Yitai Pharmaceuticals Latest Developments
Table 97. Chongqing Qingyang Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 98. Chongqing Qingyang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 99. Chongqing Qingyang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Chongqing Qingyang Pharmaceuticals Main Business
Table 101. Chongqing Qingyang Pharmaceuticals Latest Developments
Table 102. Zhejiang Chengyi Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 103. Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 104. Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Zhejiang Chengyi Pharmaceuticals Main Business
Table 106. Zhejiang Chengyi Pharmaceuticals Latest Developments
Table 107. Tianjin Junan Biopharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 108. Tianjin Junan Biopharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 109. Tianjin Junan Biopharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Tianjin Junan Biopharmaceuticals Main Business
Table 111. Tianjin Junan Biopharmaceuticals Latest Developments
Table 112. Shanghai Pharmaceuticals Kangli Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 113. Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 114. Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. Shanghai Pharmaceuticals Kangli Main Business
Table 116. Shanghai Pharmaceuticals Kangli Latest Developments
Table 117. Zhejiang Chetou Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 118. Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 119. Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 120. Zhejiang Chetou Pharmaceuticals Main Business
Table 121. Zhejiang Chetou Pharmaceuticals Latest Developments
Table 122. Mangalam Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 123. Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 124. Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 125. Mangalam Main Business
Table 126. Mangalam Latest Developments
Table 127. Adrovent Pharma Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 128. Adrovent Pharma Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 129. Adrovent Pharma Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 130. Adrovent Pharma Main Business
Table 131. Adrovent Pharma Latest Developments
Table 132. Vinuthana Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 133. Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 134. Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 135. Vinuthana Main Business
Table 136. Vinuthana Latest Developments
Table 137. Atom pharma Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 138. Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 139. Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 140. Atom pharma Main Business
Table 141. Atom pharma Latest Developments
Table 142. Clearsynth Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 143. Clearsynth Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 144. Clearsynth Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 145. Clearsynth Main Business
Table 146. Clearsynth Latest Developments
Table 1. Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Acyclovir Active Pharmaceutical Ingredient (API) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity ? 98%
Table 4. Major Players of Purity ? 99%
Table 5. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025) & (Tons)
Table 6. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
Table 7. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Type (2020-2025) & ($ million)
Table 8. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2020-2025)
Table 9. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Type (2020-2025) & (US$/Ton)
Table 10. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale by Application (2020-2025) & (Tons)
Table 11. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Market Share by Application (2020-2025)
Table 12. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Application (2020-2025) & ($ million)
Table 13. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2020-2025)
Table 14. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Application (2020-2025) & (US$/Ton)
Table 15. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Company (2020-2025) & (Tons)
Table 16. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Company (2020-2025)
Table 17. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Company (2020-2025)
Table 19. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Price by Company (2020-2025) & (US$/Ton)
Table 20. Key Manufacturers Acyclovir Active Pharmaceutical Ingredient (API) Producing Area Distribution and Sales Area
Table 21. Players Acyclovir Active Pharmaceutical Ingredient (API) Products Offered
Table 22. Acyclovir Active Pharmaceutical Ingredient (API) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Geographic Region (2020-2025) & (Tons)
Table 26. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share Geographic Region (2020-2025)
Table 27. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country/Region (2020-2025) & (Tons)
Table 30. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country/Region (2020-2025)
Table 31. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025) & (Tons)
Table 34. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2020-2025)
Table 35. Americas Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025) & (Tons)
Table 37. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025) & (Tons)
Table 38. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region (2020-2025) & (Tons)
Table 39. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2020-2025)
Table 40. APAC Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025) & (Tons)
Table 42. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025) & (Tons)
Table 43. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025) & (Tons)
Table 44. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025) & (Tons)
Table 46. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025) & (Tons)
Table 47. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025) & (Tons)
Table 48. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025) & (Tons)
Table 50. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Acyclovir Active Pharmaceutical Ingredient (API)
Table 52. Key Market Challenges & Risks of Acyclovir Active Pharmaceutical Ingredient (API)
Table 53. Key Industry Trends of Acyclovir Active Pharmaceutical Ingredient (API)
Table 54. Acyclovir Active Pharmaceutical Ingredient (API) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Acyclovir Active Pharmaceutical Ingredient (API) Distributors List
Table 57. Acyclovir Active Pharmaceutical Ingredient (API) Customer List
Table 58. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Region (2026-2031) & (Tons)
Table 59. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2026-2031) & (Tons)
Table 61. Americas Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Region (2026-2031) & (Tons)
Table 63. APAC Acyclovir Active Pharmaceutical Ingredient (API) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2026-2031) & (Tons)
Table 65. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2026-2031) & (Tons)
Table 67. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Type (2026-2031) & (Tons)
Table 69. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Forecast by Application (2026-2031) & (Tons)
Table 71. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Fuxiang Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 73. Fuxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 74. Fuxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Fuxiang Pharmaceuticals Main Business
Table 76. Fuxiang Pharmaceuticals Latest Developments
Table 77. Zhejiang Zhebei Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 78. Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 79. Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Zhejiang Zhebei Pharmaceuticals Main Business
Table 81. Zhejiang Zhebei Pharmaceuticals Latest Developments
Table 82. Hongyuan Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 83. Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 84. Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Hongyuan Pharmaceuticals Main Business
Table 86. Hongyuan Pharmaceuticals Latest Developments
Table 87. Xinxiang Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 88. Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 89. Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Xinxiang Pharmaceuticals Main Business
Table 91. Xinxiang Pharmaceuticals Latest Developments
Table 92. Hubei Yitai Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 93. Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 94. Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Hubei Yitai Pharmaceuticals Main Business
Table 96. Hubei Yitai Pharmaceuticals Latest Developments
Table 97. Chongqing Qingyang Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 98. Chongqing Qingyang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 99. Chongqing Qingyang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Chongqing Qingyang Pharmaceuticals Main Business
Table 101. Chongqing Qingyang Pharmaceuticals Latest Developments
Table 102. Zhejiang Chengyi Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 103. Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 104. Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Zhejiang Chengyi Pharmaceuticals Main Business
Table 106. Zhejiang Chengyi Pharmaceuticals Latest Developments
Table 107. Tianjin Junan Biopharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 108. Tianjin Junan Biopharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 109. Tianjin Junan Biopharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Tianjin Junan Biopharmaceuticals Main Business
Table 111. Tianjin Junan Biopharmaceuticals Latest Developments
Table 112. Shanghai Pharmaceuticals Kangli Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 113. Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 114. Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. Shanghai Pharmaceuticals Kangli Main Business
Table 116. Shanghai Pharmaceuticals Kangli Latest Developments
Table 117. Zhejiang Chetou Pharmaceuticals Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 118. Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 119. Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 120. Zhejiang Chetou Pharmaceuticals Main Business
Table 121. Zhejiang Chetou Pharmaceuticals Latest Developments
Table 122. Mangalam Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 123. Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 124. Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 125. Mangalam Main Business
Table 126. Mangalam Latest Developments
Table 127. Adrovent Pharma Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 128. Adrovent Pharma Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 129. Adrovent Pharma Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 130. Adrovent Pharma Main Business
Table 131. Adrovent Pharma Latest Developments
Table 132. Vinuthana Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 133. Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 134. Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 135. Vinuthana Main Business
Table 136. Vinuthana Latest Developments
Table 137. Atom pharma Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 138. Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 139. Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 140. Atom pharma Main Business
Table 141. Atom pharma Latest Developments
Table 142. Clearsynth Basic Information, Acyclovir Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 143. Clearsynth Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 144. Clearsynth Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 145. Clearsynth Main Business
Table 146. Clearsynth Latest Developments
LIST OF FIGURES
Figure 1. Picture of Acyclovir Active Pharmaceutical Ingredient (API)
Figure 2. Acyclovir Active Pharmaceutical Ingredient (API) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Acyclovir Active Pharmaceutical Ingredient (API) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country/Region (2024)
Figure 10. Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity ? 98%
Figure 12. Product Picture of Purity ? 99%
Figure 13. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type in 2025
Figure 14. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2020-2025)
Figure 15. Acyclovir Active Pharmaceutical Ingredient (API) Consumed in Pharmaceuticals
Figure 16. Global Acyclovir Active Pharmaceutical Ingredient (API) Market: Pharmaceuticals (2020-2025) & (Tons)
Figure 17. Acyclovir Active Pharmaceutical Ingredient (API) Consumed in Scientific Research
Figure 18. Global Acyclovir Active Pharmaceutical Ingredient (API) Market: Scientific Research (2020-2025) & (Tons)
Figure 19. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Market Share by Application (2024)
Figure 20. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Application in 2025
Figure 21. Acyclovir Active Pharmaceutical Ingredient (API) Sales by Company in 2025 (Tons)
Figure 22. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Company in 2025
Figure 23. Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Company in 2025 ($ millions)
Figure 24. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Company in 2025
Figure 25. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales 2020-2025 (Tons)
Figure 28. Americas Acyclovir Active Pharmaceutical Ingredient (API) Revenue 2020-2025 ($ millions)
Figure 29. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales 2020-2025 (Tons)
Figure 30. APAC Acyclovir Active Pharmaceutical Ingredient (API) Revenue 2020-2025 ($ millions)
Figure 31. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales 2020-2025 (Tons)
Figure 32. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales 2020-2025 (Tons)
Figure 34. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue 2020-2025 ($ millions)
Figure 35. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country in 2025
Figure 36. Americas Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2020-2025)
Figure 37. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
Figure 38. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2020-2025)
Figure 39. United States Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Region in 2025
Figure 44. APAC Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2020-2025)
Figure 45. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
Figure 46. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2020-2025)
Figure 47. China Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 51. India Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country in 2025
Figure 55. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2020-2025)
Figure 56. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
Figure 57. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2020-2025)
Figure 58. Germany Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 59. France Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2020-2025)
Figure 66. Egypt Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Acyclovir Active Pharmaceutical Ingredient (API) in 2025
Figure 72. Manufacturing Process Analysis of Acyclovir Active Pharmaceutical Ingredient (API)
Figure 73. Industry Chain Structure of Acyclovir Active Pharmaceutical Ingredient (API)
Figure 74. Channels of Distribution
Figure 75. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Forecast by Region (2026-2031)
Figure 76. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Acyclovir Active Pharmaceutical Ingredient (API)
Figure 2. Acyclovir Active Pharmaceutical Ingredient (API) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Acyclovir Active Pharmaceutical Ingredient (API) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country/Region (2024)
Figure 10. Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity ? 98%
Figure 12. Product Picture of Purity ? 99%
Figure 13. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type in 2025
Figure 14. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2020-2025)
Figure 15. Acyclovir Active Pharmaceutical Ingredient (API) Consumed in Pharmaceuticals
Figure 16. Global Acyclovir Active Pharmaceutical Ingredient (API) Market: Pharmaceuticals (2020-2025) & (Tons)
Figure 17. Acyclovir Active Pharmaceutical Ingredient (API) Consumed in Scientific Research
Figure 18. Global Acyclovir Active Pharmaceutical Ingredient (API) Market: Scientific Research (2020-2025) & (Tons)
Figure 19. Global Acyclovir Active Pharmaceutical Ingredient (API) Sale Market Share by Application (2024)
Figure 20. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Application in 2025
Figure 21. Acyclovir Active Pharmaceutical Ingredient (API) Sales by Company in 2025 (Tons)
Figure 22. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Company in 2025
Figure 23. Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Company in 2025 ($ millions)
Figure 24. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Company in 2025
Figure 25. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales 2020-2025 (Tons)
Figure 28. Americas Acyclovir Active Pharmaceutical Ingredient (API) Revenue 2020-2025 ($ millions)
Figure 29. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales 2020-2025 (Tons)
Figure 30. APAC Acyclovir Active Pharmaceutical Ingredient (API) Revenue 2020-2025 ($ millions)
Figure 31. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales 2020-2025 (Tons)
Figure 32. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales 2020-2025 (Tons)
Figure 34. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue 2020-2025 ($ millions)
Figure 35. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country in 2025
Figure 36. Americas Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2020-2025)
Figure 37. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
Figure 38. Americas Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2020-2025)
Figure 39. United States Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Region in 2025
Figure 44. APAC Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2020-2025)
Figure 45. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
Figure 46. APAC Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2020-2025)
Figure 47. China Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 51. India Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country in 2025
Figure 55. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2020-2025)
Figure 56. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
Figure 57. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2020-2025)
Figure 58. Germany Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 59. France Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2020-2025)
Figure 66. Egypt Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Acyclovir Active Pharmaceutical Ingredient (API) in 2025
Figure 72. Manufacturing Process Analysis of Acyclovir Active Pharmaceutical Ingredient (API)
Figure 73. Industry Chain Structure of Acyclovir Active Pharmaceutical Ingredient (API)
Figure 74. Channels of Distribution
Figure 75. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Forecast by Region (2026-2031)
Figure 76. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Application (2026-2031)
